Year: 2017

Page: Scoliosis Brace Awarded $50,000 from FDA-Sponsored Competition

Get ready, because a new pediatric medical device may hit the market. Judges of the National Capital Consortium for Pediatric Device Innovation competition judged 12 finalists at the Fifth Annual Pediatric Device Innovation Symposium. A total of 98 applications were submitted from across the U.S., and finalists had five minutes to pitch their devices. Half […]

Page: Strong Demand Trends to Revolutionize the Global Pediatric Neurology Device Market By 2021

The pediatric neurology devices market is developing considerably well owing to development of practices and treatment methods. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, published in its recent report on Global Pediatric Neurology Devices Market Research Report – Forecast to 2021, that the demand graph […]

Page: Press Release

Three leaders from Children’s National Health System are among the investigators of a new FDA-funded program created to launch a global clinical trials network.

Page: CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device

CorInnova Inc., an emerging medical device company developing heart failure treatments, has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic heart device to support heart function.

Page: Green Sun Medical awarded $50K for scoliosis brace at prestigious pediatric medical device competition

Fort Collins-based startup company Green Sun Medical was awarded the top prize of a $50,000 grant during the Fifth Annual Pediatric Device Innovation Symposium, which is an FDA-sponsored pediatric medical device competition in San Jose, Calif. organized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.

Page: CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function

Company Announces Residency at Johnson & Johnson Innovation’s JLABS @ TMC in the Texas Medical Center. $6.1 Million Lead Investment From UK-based The Wellcome Trust is Being Used to Develop Less-Invasive, Non-Blood-Contacting Soft Robotic Heart Device to Treat Heart Failure (HF).